Sacrococcygeal teratoma is a rare tumor that develops at the base of the spine before birth or in early infancy. Many people first hear about sacrococcygeal teratoma during a prenatal ultrasound, and the main signs are a lump near the tailbone, swelling, or pressure on the bladder or bowel. Sacrococcygeal teratoma is usually present from birth, but the size and effects can vary. Treatment is usually surgery, and some babies also need close monitoring or, less often, chemotherapy if the tumor is cancerous. The outlook is often good when care starts early, though very large tumors or tumors found late can be life-threatening in some cases.
How many people live with Sacrococcygeal teratoma?
Reliable headcounts of everyone living with sacrococcygeal teratoma are not available, so estimates are usually based on how often it shows up at birth: using the widely cited rate of about 1 in 35,000 to 40,000 live births, this suggests roughly 3,300 to 3,800 babies are born with it worldwide each year rather than a direct count of all people living with it (StatPearls, 2023; United Nations World Population Prospects, 2024). Using the same rate and about 3.6 million U.S. births in 2023, that works out to about 90 to 100 babies born with sacrococcygeal teratoma in the United States each year, again as an estimate rather than a direct headcount (StatPearls, 2023; CDC National Center for Health Statistics, 2024).
Overview
Sacrococcygeal teratomaSymptoms
Sacrococcygeal teratoma often appears as a lump or swelling near a baby's tailbone, sometimes seen before birth on ultrasound. Depending on its size and location, it can cause trouble with bowel or bladder function or breathing after birth.
Outlook and prognosis
With prompt treatment, the outlook for sacrococcygeal teratoma is often very good, especially when it is found early and fully removed. Long-term follow-up matters, because some tumors can return or affect bowel, bladder, or movement as a child grows.
Causes and risk factors
Sacrococcygeal teratoma usually starts before birth when early germ cells grow in the wrong place near the tailbone. The exact cause is often unclear, and most cases are not inherited. It is more common in girls, with no proven lifestyle or environmental cause.
Genetic influences
Genetics usually are not a major cause of sacrococcygeal teratoma. Most cases happen sporadically, without an inherited gene change. Rarely, sacrococcygeal teratoma can appear with inherited syndromes or other birth differences.
Diagnosis
Diagnosis of sacrococcygeal teratoma often starts when a lump near the tailbone is seen before birth on ultrasound or after birth on exam. Imaging such as ultrasound or MRI helps confirm it and show how far it extends.
Treatment and drugs
Treatment for sacrococcygeal teratoma usually involves surgery to remove the tumor, often soon after birth. Some babies also need imaging and blood tests before and after surgery. If the tumor is cancerous, chemotherapy may be needed.
Symptoms
Many babies are first noticed because there is a lump near the tailbone, or because scans during pregnancy show a growth in that area. In medical terms, this is sacrococcygeal teratoma; in everyday life, it can show up as a visible swelling, a full-looking belly, or pressure on the bladder or bowel. The early features of sacrococcygeal teratoma depend on whether the growth is mostly outside the body, mostly inside the pelvis, or both. Some newborns seem well at first, while others have signs related to the size of the growth and how much it affects nearby organs.
A soft or firm mass near the tailbone or between the buttocks is a common sign when sacrococcygeal teratoma grows outward. It can be small or quite large and may make diapering, cleaning, or positioning harder.
When more of the tumor is inside the pelvis or abdomen, there may be little to see from the outside. Instead, the belly may look swollen, and a newborn may seem uncomfortable or feed less well because of pressure inside the abdomen.
Pressure on the rectum or bladder can cause constipation, trouble passing stool, a weak urine stream, or difficulty emptying the bladder. Some babies also pee less often than expected or seem fussy when trying to pee or poop.
If nearby nerves are affected, there may be weakness, less movement, or reduced feeling in one or both legs. Older infants or children may seem to favor one leg or have more trouble with balance.
How people usually first notice Sacrococcygeal teratoma?
Sacrococcygeal teratoma is often first noticed before birth on a prenatal ultrasound, when doctors see a growth near the baby’s tailbone. If it is not found during pregnancy, the first signs of sacrococcygeal teratoma are usually a visible lump or swelling at the base of the spine at birth, sometimes along with trouble feeding, constipation, weakness in the legs, or trouble passing urine if the mass presses on nearby organs. In some babies the growth is mostly inside the pelvis, so how sacrococcygeal teratoma is first noticed may be through early checkups for abdominal swelling, breathing strain, or signs of heart stress in severe cases.
Types of Sacrococcygeal teratoma
Sacrococcygeal teratoma can look quite different from one baby to another, mainly based on where the growth sits in relation to the tailbone and pelvis. Doctors usually describe the types of sacrococcygeal teratoma using a well-known four-part system based on how much of the tumor is outside the body and how much is deeper inside. This matters in daily life because a mostly external tumor is often noticed right away at birth, while a deeper one may cause problems with bowel, bladder, or pressure symptoms instead. Not everyone will have the same symptoms, and some tumors are found before birth on routine ultrasound.
Type I
This type is mostly outside the body, near the tailbone, with only a small part extending inward. It is often easy to see at birth as a lump over the lower back or buttock area. Because it is mainly external, pressure symptoms on the bowel or bladder may be less noticeable than in deeper variants of sacrococcygeal teratoma.
Type II
This type has a large outer part and a noticeable portion extending into the pelvis. A baby may have a visible mass plus symptoms from pressure inside the body, such as trouble passing stool or urine. Sometimes, symptoms cluster together in recognizable ways when both the outside and inside parts are sizable.
Type III
This type has a smaller visible part on the outside and a larger portion deeper in the pelvis or abdomen. It may be less obvious at first glance, but it can cause swelling of the belly, constipation, or bladder problems. In some cases, early symptoms of sacrococcygeal teratoma are related more to internal pressure than to the outer lump.
Type IV
This type is entirely internal, with the tumor located inside the pelvis and no visible mass outside the body. Because of that, it may be found later, after symptoms such as constipation, difficulty peeing, infections, or belly fullness appear. Doctors may need imaging tests to tell this clinical variant apart from other causes of pelvic symptoms.
Can I slow down the onset of symptoms?
No. Sacrococcygeal teratoma is a growth near the tailbone that usually forms before birth, so there is no good evidence that diet, exercise, sleep, or other lifestyle changes can delay when symptoms begin or prevent the condition. What can help is finding it early on routine pregnancy scans and getting prompt specialist care after birth, since treatment is usually surgery; this can reduce complications, but it does not stop the growth from forming, and early care often makes a real difference.
What genetics can tell you about symptoms
For sacrococcygeal teratoma, genetics usually does not tell doctors much about which symptoms a baby will have, because most cases happen sporadically and are not clearly passed down in families. In most people, symptoms and how serious they are depend much more on the tumor’s size, whether it grows mostly outside or inside the body, and whether it presses on nearby organs, which can affect things like bowel movements, urination, or breathing around birth. Rarely, a sacrococcygeal tumor can be part of an inherited condition, and in those cases genetics may help explain why related birth differences happen together, but it still usually cannot predict the exact symptoms or when problems will begin.
Causes and risk factors
Many families wonder why sacrococcygeal teratoma happens during pregnancy. It usually starts very early in fetal growth, when cells near the tailbone keep growing instead of settling into normal tissues. Most cases are sporadic, so no inherited gene change is found, but rare cases are linked to changes in a gene called MNX1. Being female raises the chance of sacrococcygeal teratoma, and no clear lifestyle or environmental causes have been proven so far. Researchers are still learning how these pieces fit together.
What are the most common causes or risk factors?
The exact cause of sacrococcygeal teratoma is usually not known. It usually begins before birth, when very early cells near the baby’s tailbone grow in the wrong way; it is more common in girls, and most cases happen by chance rather than being passed down in families. Rarely, it can be linked to an inherited gene change or syndrome, but for most families there are no well-proven lifestyle, diet, or pregnancy-related risk factors.
Environmental and biological risk factors
Sacrococcygeal teratoma usually happens sporadically, and in most cases there is no clear reason why it develops. Some risks are carried inside the body, others come from the world around us. For sacrococcygeal teratoma, the clearest pattern is biological rather than environmental. No specific exposure during pregnancy has been firmly proven to cause it.
Sacrococcygeal teratoma is much more common in female babies than in male babies. This is the strongest consistent biological pattern seen across reported cases.
Researchers believe this condition begins very early in fetal development, when certain immature cells remain near the tailbone instead of settling or disappearing as expected. That early developmental change can happen without any known outside trigger.
No medicine, infection, chemical, or pollution exposure has been clearly proven to cause sacrococcygeal teratoma. For many families, this means the known risk factors for sacrococcygeal teratoma are limited, and most cases cannot be linked to a specific exposure.
Genetic risk factors
For most families, sacrococcygeal teratoma appears as a one-time event, and doctors do not find a clear inherited cause. Some risk factors are inherited through our genes. The best-known genetic link is a rare condition called Currarino syndrome, often caused by a change in the MNX1 gene. Overall, inherited genetic risk factors for sacrococcygeal teratoma are uncommon.
Sporadic cases: Most sacrococcygeal teratoma cases happen sporadically, meaning they are not traced to a gene change passed down in a family. For many parents, this means the tumor developed without a known inherited reason.
Currarino syndrome: A small number of sacrococcygeal teratomas are linked to Currarino syndrome, a rare inherited condition that affects the lower spine and nearby tissues. It is most often caused by a change in the MNX1 gene and can raise the chance of a presacral mass, which may be a teratoma.
Family history: Rare familial cases have been reported, so a family history of Currarino syndrome or similar presacral tumors can matter. If close relatives have these findings, genetic counseling may help clarify whether testing is useful.
Lifestyle risk factors
Sacrococcygeal teratoma is present from birth, so lifestyle habits do not cause it. However, how lifestyle affects sacrococcygeal teratoma can matter after treatment by influencing recovery, bowel and bladder symptoms, pelvic discomfort, and overall function. The most relevant factors are the daily habits that affect healing, pressure on the pelvic area, and long-term symptom control.
Low-fiber eating, poor hydration, and irregular toilet habits can worsen constipation, which is a common issue for some people after sacrococcygeal teratoma treatment. Straining can increase pelvic discomfort and make bowel symptoms harder to manage.
Too little movement can slow bowel function, reduce core strength, and contribute to deconditioning during recovery from sacrococcygeal teratoma surgery. Gradual, appropriate activity may support mobility, comfort, and pelvic function, while overly intense activity too soon can aggravate pain.
Carrying excess weight can increase pressure on the lower back, pelvic floor, and surgical area in people treated for sacrococcygeal teratoma. This may make sitting discomfort, leakage symptoms, or mobility problems more noticeable.
Tobacco and nicotine do not cause sacrococcygeal teratoma, but they can impair wound healing and raise the risk of complications around surgery or recovery. They may also worsen circulation and tissue repair in the sacral area.
Risk prevention
Sacrococcygeal teratoma cannot usually be prevented because it develops before birth and is most often not linked to anything a parent did or did not do. For many living with sacrococcygeal teratoma, prevention is really about lowering the chance of complications through early detection, careful delivery planning, and timely treatment. Different people need different prevention strategies—there’s no single formula.
Regular prenatal visits and ultrasound checks cannot stop sacrococcygeal teratoma from forming, but they can help find it early and track how it is affecting the baby. This can guide safer pregnancy monitoring and delivery planning.
If sacrococcygeal teratoma is seen during pregnancy, care from a maternal-fetal medicine team can help watch for rapid growth, extra fluid, or strain on the baby's heart. Early specialist input may lower the risk of emergency complications around birth.
Planning birth in a hospital with newborn surgery and intensive care support can reduce risks if the tumor is large or causing problems. This is often one of the most important ways to improve safety for both parent and baby.
After birth, early evaluation and surgery are the main ways to prevent bleeding, infection, or pressure on nearby organs. Quick treatment also helps doctors check whether the tumor has any immature or cancerous areas.
Can you prevent Sacrococcygeal teratoma?
No, there is no known way to prevent sacrococcygeal teratoma. It usually starts very early in a baby's development before birth, and it is not believed to be caused by anything a parent did or did not do. While regular prenatal care cannot stop it from happening, it can help doctors find it early and plan the safest care.
Transmission
Sacrococcygeal teratoma is not infectious, so it cannot be caught from another person through touch, breathing, sex, food, or everyday contact during pregnancy. For most families, sacrococcygeal teratoma develops as a one-time problem during early fetal growth, rather than something that spreads between people.
When people ask about genetic transmission of sacrococcygeal teratoma, the reassuring answer is that it is usually not inherited from a parent and does not typically run in families. Rarely, sacrococcygeal teratoma can occur alongside certain genetic conditions, so if there is a strong family history of birth differences or unusual tumors, a genetics specialist may help explain the chance of it happening again.
When to test your genes
Genetic testing is not routine for most sacrococcygeal teratomas, because they are usually isolated and not inherited. It may be worth discussing if the tumor occurs with anorectal or sacral abnormalities, a presacral mass, or a family history suggesting Currarino syndrome, where MNX1 testing can help guide care.
Diagnosis
Sacrococcygeal teratoma is often found before birth or soon after delivery because it can cause a visible lump near the tailbone or show up on routine pregnancy imaging. For many, the first step comes when everyday activities start feeling harder, such as trouble with feeding, constipation, swelling, or discomfort from a growing mass in an older infant or child. The diagnosis of sacrococcygeal teratoma usually combines the physical exam with imaging tests to show the size of the tumor, where it sits, and whether it extends inside the pelvis or abdomen.
Doctors check for a lump or swelling near the buttocks and tailbone area. They also look for signs that the mass is affecting nearby organs, such as bowel or bladder problems.
Many sacrococcygeal teratomas are first seen during routine pregnancy scans. Ultrasound can show the size of the mass, whether it is mostly cystic or solid, and whether it is causing complications for the fetus.
MRI helps show how far the tumor extends inside the pelvis, abdomen, or spinal area. This gives a clearer picture for treatment planning and can improve the genetic diagnosis of sacrococcygeal teratoma only when another inherited condition is also suspected.
Doctors may measure tumor markers such as alpha-fetoprotein, often called AFP, and sometimes beta-hCG. These results can support the diagnosis and are also useful later for checking response after treatment.
How is Sacrococcygeal teratoma diagnosed?
Doctors often find a sacrococcygeal teratoma during pregnancy on a routine ultrasound, or after birth when a baby has a lump near the tailbone. To confirm it and see how far it extends inside the body, they usually use imaging scans such as ultrasound and often MRI, and they may also do blood tests to look for substances that can be linked to this kind of growth. The diagnosis is usually confirmed by the scan findings and then by examining the removed tissue under a microscope after surgery; genetic testing is not usually needed.
Stages of Sacrococcygeal teratoma
Sacrococcygeal teratoma does not have defined progression stages. This is because it is usually identified as a tumor present before birth or in early infancy, rather than an illness that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, but many cases are first found on a prenatal ultrasound or during a newborn exam because of a lump near the tailbone. Doctors usually confirm it with imaging such as ultrasound or MRI and monitor it with follow-up scans, blood tests, and checks for symptoms like pain, trouble with bowel movements, or swelling, especially when watching for early symptoms of sacrococcygeal teratoma coming back after treatment.
Outlook and prognosis
The outlook for sacrococcygeal teratoma is often very good when the tumor is detected early and completely removed, especially if it is benign and treated in infancy. Prognosis is influenced by tumor size, whether it is mostly external or has significant internal pelvic extension, the presence of complications such as high-output heart failure or hydrops before birth, and whether malignant elements are found. Most newborns who undergo successful surgery survive and do well, but they need long-term follow-up because recurrence can occur, particularly if the tumor is not fully excised along with the coccyx. Malignant sacrococcygeal teratoma has a more guarded prognosis, though outcomes have improved with modern surgery and chemotherapy. Mortality is highest in severe fetal or neonatal cases with very large, highly vascular tumors causing prenatal complications, while mortality after complete treatment of uncomplicated benign tumors is low. Some children may later experience bowel, bladder, or cosmetic issues, so prognosis includes both survival and long-term function.
Long-term effects
For many living with sacrococcygeal teratoma, the long-term picture depends on the tumor’s size, whether it was removed completely, and whether nearby nerves or pelvic organs were affected. Many do very well after treatment, but some continue to have bowel, bladder, movement, or pelvic floor problems that can affect daily life as they grow. Doctors may track these changes over years to see how sacrococcygeal teratoma affects childhood, adolescence, and adulthood.
Long-term bowel effects can include constipation, trouble emptying the bowel fully, or leaking stool. These issues may show up in toilet training, school years, or later adult life and can be among the early symptoms of sacrococcygeal teratoma follow-up concerns after surgery.
Some people have trouble holding urine, emptying the bladder completely, or getting repeated urine infections. This can happen if the tumor or surgery affected nerves or structures in the pelvis.
Weakness in the muscles and nerves at the bottom of the pelvis can affect bowel and bladder control over time. For many, symptoms are mild, while others may need long-term follow-up because problems become more noticeable with growth.
If nearby nerves, muscles, or the lower spine were affected, some may have leg weakness, changes in walking, or poor balance. These effects are not universal, but they can matter more during active childhood and adolescence.
How is it to live with Sacrococcygeal teratoma?
Living with a sacrococcygeal teratoma often begins at birth, and for many families the first chapter is shaped by surgery, hospital visits, and close follow-up rather than everyday routine. Depending on the tumor’s size, location, and whether it affected nearby nerves or organs, some people may later deal with challenges such as bowel or bladder control problems, constipation, discomfort with sitting, scarring, or worries about body image, while others recover well and live with few long-term limits. It can also affect the people around you: parents and caregivers may carry ongoing stress about treatment, checkups, and the small chance of the tumor coming back, but with good medical care and support, many children and families gradually settle into a steadier, more normal rhythm.
Treatment and drugs
Sacrococcygeal teratoma is usually treated with surgery to remove the tumor, often soon after birth, and treatment may start even earlier if the growth is causing problems during pregnancy. The exact plan depends on the tumor’s size, where it sits, whether it has spread inside the pelvis or abdomen, and whether it appears noncancerous or cancerous. Treatment plans often combine several approaches. Some babies need careful monitoring before surgery, and if the tumor shows cancerous changes, doctors may add chemotherapy after surgery to lower the chance of it coming back. After treatment, regular follow-up visits and imaging are important because sacrococcygeal teratoma can sometimes return, especially in the first few years of life.
Can you cure Sacrococcygeal teratoma?
In many babies and children, sacrococcygeal teratoma, a growth near the tailbone, can be cured if it is found early and fully removed with surgery. If the growth contains cancer cells or has spread, treatment may also include chemotherapy, and regular follow-up is important because it can sometimes come back.
Non-drug treatment
For many families, care centers on procedures, close monitoring, and practical support rather than medicines alone. Sacrococcygeal teratoma is usually treated with surgery, often soon after birth, and the plan depends on the tumor’s size, location, and whether it was found before or after delivery. Supportive therapies can also help with feeding, movement, bowel or bladder function, and recovery after an operation. In some cases, treatment for sacrococcygeal teratoma in newborns starts with careful prenatal planning so delivery and surgery happen in the safest setting.
Surgery is the main treatment and usually aims to remove the tumor completely, often along with the tailbone to lower the chance of it coming back. The timing depends on the baby’s condition, the tumor’s size, and whether it is causing bleeding, pressure, or problems with nearby organs.
When the tumor is found during pregnancy, repeated ultrasounds and sometimes fetal MRI help the team watch growth, blood flow, and signs that the baby is under strain. For many, treatment begins not at the pharmacy, but with planning the safest place and time for delivery.
Large tumors can make childbirth more complicated, so some babies need delivery in a hospital with neonatal intensive care and pediatric surgery available right away. In selected cases, a planned cesarean birth may help reduce injury to the tumor during delivery.
Rarely, if a very large tumor is causing severe problems before birth, highly specialized fetal treatment may be considered. Some non-drug options are delivered by specialists, and these procedures are only used in carefully selected situations because they carry serious risks.
Your genes may have an impact on how drugs work for you
For people with sacrococcygeal teratoma, treatment is usually centered on surgery, and when medicine is needed, it is most often standard cancer treatment rather than drugs tailored to inherited gene differences. At this time, there are no widely used, well-established genetic tests that can reliably predict how someone with this condition will respond to the medicines commonly used for it. In real life, how well treatment works is usually shaped more by things like the size and type of the growth, whether it has spread, the person’s age, and overall health.
Pharmacological treatments
For many people with sacrococcygeal teratoma, medicines are not the main treatment because surgery is usually the key step. Drug treatments aren’t about fixing everything at once, but they can be important when the tumor is cancerous, has spread, comes back, or cannot be fully removed. In those situations, doctors often use chemotherapy medicines that are also used for germ cell tumors, with the exact plan depending on age, tumor type, and blood test results.
Cisplatin is one of the main drugs used when sacrococcygeal teratoma is malignant or behaves like a germ cell cancer. It is usually given with other chemotherapy medicines rather than on its own. This approach may be used after surgery or when scans and blood tests suggest more treatment is needed.
Etoposide is commonly paired with cisplatin, and sometimes with bleomycin, in treatment plans for malignant sacrococcygeal teratoma. These combinations are often chosen for people with yolk sac tumor elements, which are a common cancerous part of some tumors. In practice, this can mean several treatment cycles spaced over weeks.
Bleomycin may be added to cisplatin and etoposide in a regimen often called BEP. Doctors use it selectively because it can affect the lungs, so breathing symptoms and lung function may need close attention. Not everyone with sacrococcygeal teratoma will need bleomycin.
Carboplatin may be used instead of cisplatin in some treatment plans, especially when side effects or age-related concerns make cisplatin less suitable. It is also usually combined with other chemotherapy drugs, not used alone. Not everyone responds to the same medication in the same way.
Genetic influences
For most families, sacrococcygeal teratoma does not clearly run in the family and is usually thought to happen sporadically during early development before birth. It’s natural to ask whether family history plays a role. In most babies with sacrococcygeal teratoma, doctors do not find a single inherited gene change causing it, although rare cases can appear as part of a broader inherited condition or alongside other birth differences. One uncommon example is Currarino syndrome, which is often linked to changes in the MNX1 gene and can include a growth near the tailbone along with bowel or spinal differences. If sacrococcygeal teratoma occurs with other congenital findings or there is a strong family history of similar problems, a genetics specialist may recommend counseling or testing to help clarify whether there is an inherited cause.
Is Sacrococcygeal teratoma genetic?
Genetics usually are not a major cause of sacrococcygeal teratoma. Most cases happen sporadically, without an inherited gene change. Rarely, sacrococcygeal teratoma can appear with inherited syndromes or other birth differences.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal feature of human biology and are widespread across the population. Most do not directly affect health and simply reflect natural differences between people. In many genes, having a variant connected with a condition suggests a possible link, not a certain diagnosis, particularly when several genes and environmental factors play a role. Still, in some situations, one well-studied variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families facing sacrococcygeal teratoma, the biggest treatment questions are usually whether surgery is enough and whether chemotherapy will be needed later. In most cases, inherited genes do not strongly direct the first treatment, and care is guided more by the tumor’s size, where it sits, whether it can be fully removed, and whether it shows cancerous changes. Most sacrococcygeal teratomas are not tied to a single inherited gene change, so routine genetic testing usually does not decide the main treatment plan. If chemotherapy is needed for malignant or recurrent sacrococcygeal teratoma, doctors usually choose standard medicines based on the tumor type and the child’s overall health rather than a specific gene result. Not every difference in response is genetic, but genes can affect how some children process cancer drugs, so the care team may adjust doses and watch closely for side effects such as low blood counts, kidney problems, or hearing changes. For many families asking about treatment for sacrococcygeal teratoma in newborns, this means genetics may add some context, but surgery, what the tumor shows under the microscope, and careful follow-up remain the main guides.
Interactions with other conditions
Sacrococcygeal teratoma can affect more than the tumor itself, because many babies also need careful checks for problems in nearby organs and structures. Another important aspect is how it may link with other diseases. In some children, sacrococcygeal teratoma occurs along with changes in the lower spine, bowel, bladder, or pelvic area, which can lead to constipation, trouble emptying the bladder, or weakness in the legs. These related problems may still matter even after treatment, so follow-up care often includes looking at movement, toilet function, and growth, not just whether the mass has been removed. Early symptoms of sacrococcygeal teratoma can also overlap with signs of infection, bowel blockage, or other growths near the tailbone, which is one reason doctors usually use imaging to sort out what is going on. Interactions can look very different from person to person, and the outlook often depends on the size of the tumor, whether it caused strain on the heart before birth, and whether there are any other birth differences alongside it.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Sacrococcygeal teratoma?
Other problems that can look like a sacrococcygeal teratoma include a spinal birth difference called spina bifida, a harmless fatty lump, a blood-vessel growth, or a cyst or infection near the tailbone. These can also cause a lump or swelling in the same area, and sometimes pressure symptoms such as constipation or trouble peeing. Rare growths that start in the tailbone itself can look similar too, so doctors usually need scans to tell them apart.
History
Long before scans were available, sacrococcygeal teratoma was usually noticed as a visible mass near a baby’s tailbone at birth. For families, this could mean an unexpected moment in the delivery room, followed quickly by questions about breathing, feeding, bowel movements, and what treatment would be needed right away. Early doctors described these growths by what they could see and feel, and for many years understanding was limited because the tumor can contain several different kinds of body tissue.
In recent decades, awareness has grown as ultrasound during pregnancy has made it possible to detect many cases before birth. That changed the history of sacrococcygeal teratoma in an important way: instead of first being recognized during delivery, it may now be found on a routine prenatal scan, sometimes weeks or months earlier. This helped doctors track how the tumor can affect a baby before birth, including blood flow, growth, and the amount of amniotic fluid, and it also gave families more time to plan delivery and newborn care.
As medical science evolved, doctors developed better ways to classify these tumors based on where they sit in relation to the pelvis and how much of the growth is outside or inside the body. Surgery became safer over time, and outcomes improved as newborn anesthesia, intensive care, imaging, and pathology advanced. Researchers later identified a genetic cause in some tumors at the cellular level, which helped explain why these growths form, but the main lessons from the history of sacrococcygeal teratoma have come from careful observation, earlier diagnosis, and better surgical care. Knowing this history helps explain why early symptoms of sacrococcygeal teratoma and the timing of treatment matter so much, especially in the first days of life.